Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? (Q34150865)

31 July 2017

title

Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? (English)

1 reference

31 July 2017

1 reference

Werner J Schmidt

1

1 reference

31 July 2017

Andreas Mayerhofer

series ordinal

2

1 reference

31 July 2017

Anja Meyer

series ordinal

3

1 reference

31 July 2017

Karl-A Kovar

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

31 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

31 July 2017

volume

330

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

251-254

1 reference

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900823-6

7 January 2021

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900823-6

7 January 2021

Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900823-6

7 January 2021

De novo onset of Parkinson's disease after antidepressant treatment with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900823-6

7 January 2021

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900823-6

7 January 2021

10.1016/S0304-3940(02)00823-6

Identifiers

DOI

1 reference

31 July 2017

1 reference